Zobrazeno 1 - 6
of 6
pro vyhledávání: '"François Calais"'
Publikováno v:
Cochrane Database of Systematic Reviews.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e85b8070ba799da673025f736d432630
https://doi.org/10.1002/14651858.cd014907
https://doi.org/10.1002/14651858.cd014907
Autor:
Roberto Ferrara, Martina Imbimbo, Corynne Marchal, Reem Malouf, François Calais, Sophie Paget-Bailly, Virginie Westeel
Publikováno v:
Cochrane Database Syst Rev
Background Immune checkpoint inhibitors (ICIs) targeting the PD‐1/PD‐L1 axis have changed the first‐line treatment of people with advanced non‐small cell lung cancer (NSCLC). Single‐agent pembrolizumab (a PD‐1 inhibitor) is currently the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbaa9a21adaf7079f9fa4c5a683c3620
https://doi.org/10.1002/14651858.cd013257.pub3
https://doi.org/10.1002/14651858.cd013257.pub3
Autor:
Roberto Ferrara, Martina Imbimbo, Sophie Paget-Bailly, Reem Malouf, François Calais, Giorgio Maria Agazzi, Corynne Marchal, Virginie Westeel
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary To determine the efficacy and safety of first‐line immune checkpoint inhibitors, or immuno‐oncology therapy (IO), as monotherapy or in combination for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6eb9bc543df695d5cc881a1206a28fd
https://europepmc.org/articles/PMC6364791/
https://europepmc.org/articles/PMC6364791/
Autor:
Philippe Fagnoni, Julie Vardanega, Angélique Vienot, François Calais, Claire Gerard, Christophe Borg, Samuel Limat, Franck Daval, Virginie Nerich, Marine Jary
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 86, pp.207-216. ⟨10.1016/j.ejca.2017.08.035⟩
European Journal of Cancer, Elsevier, 2017, 86, pp.207-216. 〈10.1016/j.ejca.2017.08.035〉
European Journal of Cancer, Elsevier, 2017, 86, pp.207-216. ⟨10.1016/j.ejca.2017.08.035⟩
European Journal of Cancer, Elsevier, 2017, 86, pp.207-216. 〈10.1016/j.ejca.2017.08.035〉
International audience; Objectives: The economic evaluation (EE) of healthcare interventions has become a necessity. However, high quality needs to be ensured in order to achieve validated results and help making informed decisions. Thus, the objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53bec1ef0043aa5d02027fc72aaa8dbd
https://www.hal.inserm.fr/inserm-01620966/file/Gerard_Eur_J_Cancer_17.pdf
https://www.hal.inserm.fr/inserm-01620966/file/Gerard_Eur_J_Cancer_17.pdf
Autor:
Sophie Paget-Bailly, Ludovic Trinquart, Maurice Pérol, Héloïse Pana-Katatali, François Calais, Virginie Westeel, Franck Bonnetain, David Pérol, Valérie Paulus
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: In patients with advanced NSCLC: to establish clinical effectiveness, in terms of overall survival (OS) and progression free survival and (PFS), of maintenance th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8497e415f8f0c4fe992e2147ac99b7b
https://europepmc.org/articles/PMC6491292/
https://europepmc.org/articles/PMC6491292/
Autor:
Ludovic Trinquart, Virginie Westeel, Stefano Kim, Franck Bonnetain, François Calais, Sophie Paget-Bailly
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: In patients with advanced (Stage IIIB and IV) NSCLC with EGFR wild‐type, unknown status of EGFR, or with EGFR activating mutations (Mountain 1997), to assess in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9095aa94207a24440dcf2ff3f832fb
https://doi.org/10.1002/14651858.cd011291
https://doi.org/10.1002/14651858.cd011291